MEREDITH LEE: Open Payments
NPI 1760017024 · ASHEVILLE, NC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$845 in 26 payments from 15 companies in 2025. Trend: 2023 $73 · 2024 $264 · 2025 $845
Food & beverage: $845
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 6 | $208 |
| Neurocrine BioSciences, Inc. | 3 | $137 |
| Exact Sciences Corporation | 3 | $136 |
| AstraZeneca Pharmaceuticals LP | 1 | $113 |
| ABBVIE INC. | 2 | $41 |
| Lilly USA, LLC | 2 | $39 |
| Otsuka America Pharmaceutical, Inc. | 1 | $27 |
| Gilead Sciences, Inc. | 1 | $26 |
| Indivior Inc. | 1 | $25 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 1 | $18 |
Products named: Ozempic, INGREZZA, The Cologuard Plus Collection Kit, AIRSUPRA, Wegovy, VRAYLAR, MOUNJARO, ABILIFY ASIMTUFII.
Industry payments across NC — which companies pay providers there.
